AMENDMENT No. 3 to AGREEMENT BETWEEN TIIE REGENTS OF THE UNIVERSITY OF CALIFORNIA AS MANAGEMENT AND OPERATIONS CONTRACTOR FOR THE LAWRENCE BERKELEY NATIONAL LABORATORY AND BERKELEY HEARTLAB, A CALIFORNIA CORPORATION
Exhibit 10.16
* Confidential Treatment Requested by Celera Corporation*
AMENDMENT
No. 3 to AGREEMENT
BETWEEN
TIIE REGENTS OF THE UNIVERSITY OF CALIFORNIA
AS MANAGEMENT AND OPERATIONS CONTRACTOR
FOR THE XXXXXXXX BERKELEY NATIONAL LABORATORY
AND
BERKELEY HEARTLAB,
A CALIFORNIA CORPORATION
The parties hereby agree to amend the Agreement as follows:
1. Revise Appendix A (February 6, 1997) with the attached Statement of Work and “BHL Project Timetable and Reporting Schedule”
2. Revise Article II. Term and Termination to include the termination date April 30, 1999.
3. Revise Article III. Cost to reduce the estimated work contemplated to $[* * * ].
4. All other terms and conditions remain unchanged and in full force and effect.
In witness whereof the parties hereto have executed this Amendment to the Agreement.
|
UNIVERSITY OF CALIFORNIA |
|
REQUESTOR: Berkeley HeartLab |
||||||||
|
|
|
|
||||||||
|
|
|
|
||||||||
|
By |
/s Xxxx X. Xxxxx |
|
By |
/s/ Xxxxx Xxxxxxxx |
||||||
|
Title |
Senior Contracts Office |
|
Title |
CEO |
||||||
|
Name |
Xxxx X. Xxxxx |
|
Name |
Xxxxx Xxxxxxxx |
||||||
|
Date |
10/22/98 |
|
Date |
10/21/98 |
||||||
* Confidential Treatment Requested by Celera Corporation*
Appendix A
Amendment 3
Statement of Work
Xxxxxx Xxxxxxx Xxxxxxxx Berkeley National Laboratory (LBNL) will:
1.) Further develop and perfect [* * *]
2.) Provide support and assistance to the clinical laboratory of BHL as needed for quality assurance, technical needs, and transfer of technology involving new or modified clinical laboratory tests.
3.) Continue responsibility for the pickup and disposal of hazardous chemical waste at the clinical laboratory:
Staff:
LBNL staff members responsible for the work in this contract include:
Xxxxxx X. Xxxxxx, M.D., Principal Investigator
Xxxxxxxx X. Xxxxxxx, Scientist and Leader, Lipoprotein Analysis Core Laboratory
Xxxxx X. Xxxx, Principal Research Associate
Xxxxxx X. Xxx, Senior Research Associate
Xxxxx X. Xxxxxxxx, R.N., Clinical Coordinator, Cholesterol Research Center
Xxxxx X. Xxxxxxx, Ph.D., Staff Scientist
Xxxxx X. Xxx, Database Manager
LBNL will notify BHL if staff members change.
Space
The primary site for the conduct of this research shall be within that occupied by the Cholesterol Research Center (currently 0000 Xxxxxxxxx Xxxxxx, Xxxxxxxx, XX). The
February 11, 1998
* Confidential Treatment Requested by Celera Corporation*
Appendix A Revision for Amendment No. 3
Statement of Work
Xxxxxx Xxxxxxx National Laboratory will further develop and [* * *] Performance, progress, and advance payments, will be monitored in accordance with the attached BHL, Project Timetable and Reporting Schedule.
The primary site for the conduct of this research shall be within that occupied by the Cholesterol Research Center (currently 0000 Xxxxxxxxx Xxxxxx, Xxxxxxxx, XX). The lease for this space shall be held by BHL. If BHL elects to renegotiate the lease with the owner, or to lease space elsewhere, the amount of space made available to LBNL will be determined by mutual agreement of BHL and LBNL. While occupying this space, LBNL will provide support to the clinical laboratory of Berkeley HeartLab (BHL). This support will be determined by mutual agreement of BHL and LBNL for quality assurance, technical needs, and transfer of technology involving new or modified clinical laboratory tests.
* Confidential Treatment Requested by Celera Corporation*
BHL Project Timetable and Reporting Schedule
Weeks
|
Project Phase |
|
1 |
|
2 |
|
3 |
|
4 |
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
|
19 |
|
20 |
|
21 |
|
22 |
|
23 |
|
24 |
|
|
Software Devel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Instrumentation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reagent Testing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sample Analysis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Data Analysis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Testing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gel Devel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Report Software |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Instrument evaluation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Advance Payment Schedule
|
Week 1 |
|
$[***] |
|
|
It is understood that work will not commence until the first advance payment has been received by LBNL. It is further understood that reports will occur at the intervals outlined below. Work will not begin on the next interval until the advance for that interval has been received. Before the commencement of the last interval, beginning Week 19, a full review of the progress will be made. Any adjustment, if required, of the benchmark, reporting, and/or advance payments will be negotiated before the commencement of the last interval. |
|
Week 7 |
|
$[***] |
|
|
|
|
Week 13 |
|
$[***] |
|
|
|
|
Week 19 |
|
$[***] |
|
|
|
|
Total |
|
$[***] |
|
|
|
|
|
|
|
|
|
PROJECT REPORTING INTERVALS
Work Commences the Week of October 19, 1998
|
Project Reporting: |
|
[***] |
|
4
